Joshua C. Doloff, Ph.D.
Specific emphasis will be applied toward engineering improved therapies in the fields of cancer, autoimmunity and transplantation medicine (i.e. type 1 diabetes), and ophthalmology.
Joshua is an alumni of The Langer Lab at the Massachusetts Institute of Technology. The Langer Labs work is at the interface of biotechnology and materials science. The major focus is the study and development of polymers to serve as scaffolds for tissue engineering and as vehicles for controlled delivery of drugs including small molecules, proteins, DNA and RNAi. Moreover, The Langer Lab is devoted to inventing novel medical devices for diagnosis and therapeutics. The Langer Lab has also established several high-throughput screening platforms for new drug development and vaccine design to treat cancers and other diseases. Last but not least, The Langer Lab is interested in cell engineering via chemical and genetic tools for cancer immunotherapy and stem cell therapy.